RA0134

antibody from Oursmab
Targeting: CD96 TACTILE
Provider product page for RA0134
Western blot
ELISA
Immunocytochemistry
Flow cytometry
Functional assay

Antibody data

Product number
RA0134 - Provider product page
Provider
Oursmab
Product name
Nelistotug (Biosimilar Reference Antibody) (CD96)
Antibody type
Monoclonal
Description
Nelistotug (also known as GSK6097608) is a human IgG1-kappa monoclonal antibody that specifically targets CD96 (T-cell-activated increased late expression, TACTILE), an immune checkpoint receptor belonging to the immunoglobulin superfamily. As an IgG1 isotype, it is designed to engage immune effector functions such as antibody-dependent cellular cytotoxicity (ADCC) and/or block receptor-ligand interactions. CD96 is primarily expressed on natural killer (NK) cells and T cells, where it binds to ligands such as CD155 (PVR) and CD111 (Nectin-1), often transmitting inhibitory signals. By binding to CD96, nelistotug aims to block these interactions, thereby reversing immune suppression and enhancing NK-cell and T-cell anti-tumor activity. It is being developed as an immune checkpoint inhibitor for the treatment of advanced solid tumors.
Reactivity
Human
Isotype
IgG
Vial size
100 ¦Ìg,1 mg,5 mg,10 mg,25 mg,50 mg,100 mg
Concentration
Bottled at the concentration indicated on the vial.
Storage
Store at -20¡ãC or -80¡ãC. Avoid repeated freeze.
CD96 protein structure - RA0134 shown in red.